CompoAtlas

TAIANTANG QILIN PILL

TAIANTANG QILIN PILL : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Polygonum multiflorumPolygonum multiflorum[0.48 gm,6 gm]Not identified
Eclipta prostrataEclipta prostrata[0.225 gm,6 gm]Not identified
Epimedium sagittatumEpimedium sagittatum[0.18 gm,6 gm]Not identified
Cuscuta chinensisCuscuta chinensis[0.192 gm,6 gm]Not identified
CYNOMORIUM SONGARICUM RUPRCYNOMORIUM SONGARICUM RUPR[1.2 gm,6 gm]Not identified
Codonopsis tangshenCodonopsis tangshen[0.42 gm,6 gm]Not identified
Lycium barbarumLycium barbarum[0.216 gm,6 gm]Not identified
Rubus chingiiRubus chingii[0.18 gm,6 gm]Not identified
Dioscorea oppositaDioscorea opposita[0.3 gm,6 gm]Not identified
Salvia miltiorrhizaSalvia miltiorrhiza[0.39 gm,6 gm]Not identified
Astragalus membranaceusAstragalus membranaceus[0.3 gm,6 gm]Not identified
Citrus reticulataCitrus reticulata[0.086 gm,6 gm]Not identified
Morus albaMorus alba[0.144 gm,6 gm]Not identified
Paeonia lactifloraPaeonia lactiflora[1.2 gm,6 gm]Not identified
Curcuma wenyujinCurcuma wenyujin[0.42 gm]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL21096085T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
ZBT FAR EAST SDN. BHD.
Manufacturer
GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD
Importer
ZBT FAR EAST SDN. BHD.
Registration period starting
2026-09-24
Published validity end
2031-09-24

Original register data

View published fields and their variants
Active ingredients
Polygonum multiflorum[0.48 gm,6 gm],Eclipta prostrata[0.225 gm,6 gm],Epimedium sagittatum[0.18 gm,6 gm],Cuscuta chinensis[0.192 gm,6 gm],CYNOMORIUM SONGARICUM RUPR[1.2 gm,6 gm],Codonopsis tangshen[0.42 gm,6 gm],Lycium barbarum[0.216 gm,6 gm],Rubus chingii[0.18 gm,6 gm],Dioscorea opposita[0.3 gm,6 gm],Salvia miltiorrhiza[0.39 gm,6 gm],Astragalus membranaceus[0.3 gm,6 gm],Citrus reticulata[0.086 gm,6 gm],Morus alba[0.144 gm,6 gm],Paeonia lactiflora[1.2 gm,6 gm],Curcuma wenyujin[0.42 gm]
Valid until
2031-09-24
Registration date
2026-09-24
Published description
NATURAL PRODUCT
Licence holder
ZBT FAR EAST SDN. BHD.
Importer
ZBT FAR EAST SDN. BHD.
Producer
GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD
Published name
TAIANTANG QILIN PILL
Published reference
202011184503T
Registration number
MAL21096085T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL21096085T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Health Canada monograph dated 30 May 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line